Chk2 Inhibitor
![]() |
- ₹0
- Product name: Chk2 Inhibitor
- CAS: 724708-21-8
- MF: C15H13N5O2
- MW: 295.3
- EINECS:-0
- MDL Number:MFCD22380609
- Synonyms:Chk2 Inhibitor;Chk2 Inhibitor - CAS 724708-21-8 - Calbiochem;Azepino[3,4-b]indol-1(2H)-one, 5-(2-amino-1,5-dihydro-5-oxo-4H-imidazol-4-ylidene)-3,4,5,10-tetrahydro-, (5Z)-;SC 203885;SC203885;SC-203885
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|
Properties
storage temp. :-20C
solubility :DMSO: Soluble
form :Pale yellow solid
solubility :DMSO: Soluble
form :Pale yellow solid
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|
Description
Chk2 Inhibitor is an indoloazepine checkpoint kinase inhibitor that mediates apoptosis and cell cycle arrest. Checkpoint kinase 2 is activated upon DNA damage or genomic instability which eventually causes apoptosis. Mechanistic studies show that Chk2 inhibitor causes autophosphorylation of Chk2 at Thr68 and targets ATP binding pockets of Chk2. Further studies demonstrate that Chk2 inhibitors also inhibit Chk1 and MEK-1 and affect interleukin-2 (IL-2), TNF-α, MEK-1, and GSK-3β.More related product prices
Motesanib 371242-69-2 N-[4-[5-(1,3-BENZODIOXOL-5-YL)-3-METHOXY-1H-1,2,4-TRIAZOL-1-YL]PHENYL]-2-(PHENYLTHIO)ACETAMIDE JNJ-10198409 Pictilisib (GDC-0941) GSK-3β Inhibitor XVIII MIF Antagonist, ISO-1 NSC697923 NSC 23766 TETRAHYDROCHLORIDE 53188-07-1 C2 CERAMIDE PD 173074 ERK Inhibitor Compound 23 648926-15-2 Compound 28Related product price
- N-[4-[5-(1,3-BENZODIOXOL-5-YL)-3-METHOXY-1H-1,2,4-TRIAZOL-1-YL]PHENYL]-2-(PHENYLTHIO)ACETAMIDE
₹25060.01 - JNJ-10198409
₹19050-78719.4 - GSK-3β Inhibitor XVIII
₹14260